Neurogene Inc.

NGNE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $52.0M $32.3M $39.5M $14.9M $11.0M $2.0M $9.2M
Accounts Receivable
Inventory
Total Current Assets $108.8M $103.5M $74.8M $39.3M $15.3M
Property, Plant & Equipment $905.0K $849.0K $89.0K $105.0K $75.5K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $110.3M $154.4M $113.3M $41.4M $15.6M
Liabilities
Accounts Payable $6.0M $6.9M $2.2M $734.0K $599.8K
Total Current Liabilities $11.0M $9.5M $4.8M $5.2M $2.6M
Long-Term Debt
Total Liabilities $11.4M $9.7M $4.9M $5.3M $7.5M
Stockholders' Equity
Retained Earnings $-198.5M $-148.3M $-111.3M $-89.4M $-65.7M
Total Stockholders' Equity $98.9M $144.7M $108.4M $36.1M $-65.7M $-51.1M $-39.3M
← Newer Page 2 of 2 Older →